Marshall Edwards, Inc. (NASDAQ:MSHL)
| CAPS Rating |
|
|---|---|
| Open | $1.04 |
| Previous Close | $1.03 |
| Daily Range | $0.98 - $1.05 |
| 52-Week Range | $0.92 - $3.28 |
| Market Cap | $9.98M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 59,731 |
| Average Daily Volume | 0 |
MSHL
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MSHL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MSHL News and Commentary
- Stocks Struggle Amid European Worries, Weak Housing Report; Commodities Mixed – NASDAQ
- Mid-Day Update: Stocks Pare Some Losses But Remain in Red; Europe in Spotlight – NASDAQ
- HEADLINE STOCKS-U.S. small/midcap stocks on the move on June 1 – Reuters
- HEADLINE STOCKS-U.S. small/midcap stocks on the move on June 1 – Reuters
- UPDATE 1-Marshall Edwards cancer drug fails late-stage study – Reuters
- 7 Surprising 1-Star Stocks – The Motley Fool
- Dendreon Tries to Pick Up the Pieces – The Motley Fool
- 7 Surprising 1-Star Stocks – The Motley Fool
Related News and Articles
- The Skinny on Upcoming Obesity FDA Meetings – The Motley Fool
- All Good Things Must Come to an End – The Motley Fool
- 1 Biotech to Buy Post-Plunge – The Motley Fool
- Modified Study, Same Bloody Results – The Motley Fool
- Buy, Sell, or Hold: Ariad Pharmaceuticals – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- Merck Investors Can Sleep Easier (Not Easy) – The Motley Fool
- Is This Situation Special Enough? – The Motley Fool
- Investments for Income Lovers – The Motley Fool
- The Highest-Yielding Dow Stocks – The Motley Fool
RSS Headlines
Fool UK
